Sourced from GMP · ISO · Halal · Kosher certified facilities · FSSAI & APEDA registered exporter📞 +91 8767675175info@svbotanica.com
Nutraceuticals
Quick Specs
CAS107-35-7
Purity≥99.0% (USP/BP)
SourceSynthetic
Shelf life24 months
MOQ1 kg (sample); 25 kg (commercial)
Nutraceuticals

Taurine

Sulfonic Acid Amino Acid Cardiovascular & Sports Energy Drink Grade CAS 107-35-7
The heart's most abundant amino acid — taurine protects cardiomyocytes, reduces blood pressure, improves exercise endurance, and anchors the global energy drink market at 1g per can.
Taurine is a unique sulfonic acid amino acid that functions not as a protein building block but as a free-form intracellular signalling molecule — stabilising cardiac membranes, regulating calcium flux, scavenging hypochlorite, and maintaining cell volume under osmotic stress. Its highest tissue concentrations are in the retina (50 mmol/kg), heart (30 mmol/kg), and brain, where deficiency causes irreversible damage.

SV Botanica supplies pharmaceutical-grade Taurine (≥99.0%, USP/BP) for cardiac, ophthalmic, and clinical nutrition applications, and food-grade Taurine for sports and energy drink formulations — synthesised, GMP-certified, with full traceability documentation.
Available specifications
    Quality Assurance

    Synthetic Purity. USP/BP Compliant. Cardiac-Grade Specification.

    Every batch HPLC-assayed for ≥99% purity, heavy metals, microbial limits, and residual solvents. Used in pharmaceutical cardiac formulations — GMP documentation to pharmaceutical standard.

    01

    HPLC purity verification

    Assay ≥99.0% by HPLC and potentiometric titration. Identity confirmed by IR spectroscopy. Melting point 305°C verified. Related amino acid impurities and sulfate content profiled per USP/BP.

    02

    Residual solvent testing

    Synthetic grade tested for residual solvents (ICH Q3C limits). Aziridine residuals below detection limit. Sulfur dioxide below ICH Class 3 limits. Full ICH residual solvent profile on request.

    03

    Heavy metals and microbial safety

    Lead NMT 0.5 ppm; Arsenic NMT 0.5 ppm; Mercury NMT 0.1 ppm. TPC NMT 10³ CFU/g; absence of Salmonella and E. coli. Tested per USP/EP methods on each batch.

    04

    Export documentation

    Full COA, MSDS, Certificate of Origin. USP/BP analytical certificates. FSSAI compliance for food applications. Halal/Kosher on request. Suitable for infant formula applications with full documentation.

    Formulation Intelligence

    Taurine Buyer's Guide: Cardiovascular vs Sports vs Energy Drink Applications

    Taurine serves three distinct end markets with different dosing rationales: pharmaceutical cardiac formulations (1.5–3g/day), sports supplements (1–2g pre-exercise), and energy drinks (1g/250mL standard). All use the same ingredient — the application context and dose separate them.

    Cardiovascular

    Cardiac & Blood Pressure

    1.5–3g/day · Meta-analysis confirmed BP reduction

    Taurine is used in cardiac medicine in Japan as a registered pharmaceutical for congestive heart failure (3g/day). Meta-analyses confirm 1.5–3g/day reduces systolic BP by 4 mmHg and diastolic BP by 2 mmHg. Mechanism: stabilises cardiac membrane potential, regulates intracellular Ca²⁺ in cardiomyocytes, reduces oxidative stress in heart tissue. Specify pharmaceutical grade with USP/BP COA for this application.

    Best for: Cardiac supplement formulations, blood pressure management, heart failure support.
    Sports

    Exercise Performance

    1–2g pre-exercise · DOMS reduction · Endurance

    1–2g taurine 60–90 minutes pre-exercise reduces exercise-induced oxidative damage, attenuates post-exercise muscle soreness (DOMS), and extends time-to-exhaustion in endurance events. Mechanism: osmotic regulation in muscle cells, calcium-mediated force production support. Food grade is appropriate; cost advantage over pharma grade at these high-volume sports doses.

    Best for: Pre-workout formulas, post-exercise recovery blends, endurance sports supplements.
    Energy Drinks

    1g/250 mL Standard

    Global energy drink standard · Highly water-soluble

    The energy drink industry standard is 1g taurine per 250mL can (Red Bull, Monster, and most major brands). Taurine is beverage-optimised: highly soluble, thermally stable through pasteurisation and UHT, pH stable at acidic beverage pH (2.5–4.0), and flavour-neutral. Specify beverage-grade or food-grade. Taurine counterbalances caffeine's pro-arrhythmic effects and reduces jitteriness.

    Best for: Energy drink formulation, RTD beverages, electrolyte drinks.
    Eye & Infant

    Retinal & Neonatal

    Retina: 50 mmol/kg · Infant formula: 4–6 mg/100kcal

    Taurine is conditionally essential for neonates (premature infants cannot synthesise sufficient amounts) and is mandated in EU/FDA infant formula regulations at 4–6mg/100kcal. For eye health: taurine deficiency causes irreversible photoreceptor degeneration — supplementation is used in retinal protective formulations. Pharmaceutical grade with infant formula documentation required for neonatal applications.

    Note: Pharmaceutical grade required for infant formula; full regulatory documentation provided.
    Buyer FAQ

    Frequently Asked Questions

    Taurine (1g/250mL) serves multiple roles: counterbalances caffeine's pro-arrhythmic effects by stabilising cardiac membrane potential; reduces caffeine-induced jitteriness via GABA-A/glycine receptor modulation; enhances cognition additively with caffeine — RCTs show taurine + caffeine improves reaction time more than caffeine alone; supports physical endurance by reducing exercise-induced oxidative damage. Despite myths, taurine is not derived from bull semen or urine — it is synthetically produced.
    Cardiovascular: 1.5–3g/day in divided doses. Meta-analyses confirm reduction in systolic BP (−4 mmHg) and diastolic BP (−2 mmHg) over 4–12 weeks. Heart failure: 3g/day shown to improve NYHA class. Sports performance: 1–2g 60–90 minutes pre-exercise. Reduces DOMS and improves time-to-exhaustion. Eye health: 250–500mg/day typical. Neonatal infant formula: 4–6mg/100kcal (mandated).
    Taurine is among the safest amino acid supplements. No adverse effects at doses up to 3g/day in long-term human trials. EFSA assessed taurine in energy drinks and concluded 3g/day poses no safety concern. At very high doses (>6g/day), gastrointestinal discomfort possible. No known drug interactions. Safe in pregnancy (present in breast milk). Taurine has cardioprotective properties — concern about energy drinks is related to caffeine, not taurine.
    The retina contains the highest taurine concentration of any tissue (≥50 mmol/kg). Taurine in photoreceptors: (1) maintains structural integrity of rod and cone outer segments; (2) protects against phototoxic oxidative damage; (3) regulates calcium homeostasis in photoreceptors; (4) modulates retinal ganglion cell survival via GABA-A signalling. Taurine deficiency is the established cause of feline retinal degeneration. Depletion by vigabatrin (anti-epileptic) causes retinal dysfunction in humans.
    Taurine is highly stable: (1) highly water-soluble (10.5g/100mL) — excellent for beverages; (2) thermally stable through pasteurisation and UHT processing; (3) pH stable across 2–10 — compatible with acidic energy drink matrices; (4) no significant Maillard reactivity with sugars; (5) hygroscopic at high humidity — sealed packaging required. Shelf life: 24 months at <25°C. No known incompatibilities at supplement concentrations.